CH207499A - Process for separating the carbonyl compounds obtainable in the side chain degradation of steroids. - Google Patents
Process for separating the carbonyl compounds obtainable in the side chain degradation of steroids.Info
- Publication number
- CH207499A CH207499A CH207499DA CH207499A CH 207499 A CH207499 A CH 207499A CH 207499D A CH207499D A CH 207499DA CH 207499 A CH207499 A CH 207499A
- Authority
- CH
- Switzerland
- Prior art keywords
- carbonyl compounds
- carbonyl
- side chain
- steroids
- ether
- Prior art date
Links
- 150000001728 carbonyl compounds Chemical class 0.000 title claims description 15
- 238000000034 method Methods 0.000 title claims description 8
- 230000015556 catabolic process Effects 0.000 title claims description 7
- 238000006731 degradation reaction Methods 0.000 title claims description 7
- 150000003431 steroids Chemical class 0.000 title claims description 5
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 9
- 238000000926 separation method Methods 0.000 claims description 9
- 239000003153 chemical reaction reagent Substances 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- 238000006243 chemical reaction Methods 0.000 claims description 4
- 238000003776 cleavage reaction Methods 0.000 claims description 4
- 239000007859 condensation product Substances 0.000 claims description 4
- 230000007017 scission Effects 0.000 claims description 4
- 229920006395 saturated elastomer Polymers 0.000 claims description 3
- 238000009833 condensation Methods 0.000 claims description 2
- 230000005494 condensation Effects 0.000 claims description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 26
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 22
- 239000000243 solution Substances 0.000 description 15
- 229960000583 acetic acid Drugs 0.000 description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- 238000000605 extraction Methods 0.000 description 7
- 230000003647 oxidation Effects 0.000 description 7
- 238000007254 oxidation reaction Methods 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 239000012452 mother liquor Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 4
- 229940042795 hydrazides for tuberculosis treatment Drugs 0.000 description 4
- 239000000155 melt Substances 0.000 description 4
- 230000007935 neutral effect Effects 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 3
- 230000001476 alcoholic effect Effects 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000012259 ether extract Substances 0.000 description 3
- 239000012362 glacial acetic acid Substances 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol group Chemical class OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 150000007857 hydrazones Chemical class 0.000 description 3
- 150000002576 ketones Chemical class 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 2
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical class CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- LDEKDFZOPHVUAB-UHFFFAOYSA-N acetic acid;dihydrobromide Chemical compound Br.Br.CC(O)=O LDEKDFZOPHVUAB-UHFFFAOYSA-N 0.000 description 2
- CQVJBJWAISQFCL-UHFFFAOYSA-N acetohydrazide;n,n-dimethylmethanamine Chemical compound CN(C)C.CC(=O)NN CQVJBJWAISQFCL-UHFFFAOYSA-N 0.000 description 2
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 238000007256 debromination reaction Methods 0.000 description 2
- FMGSKLZLMKYGDP-USOAJAOKSA-N dehydroepiandrosterone Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC=C21 FMGSKLZLMKYGDP-USOAJAOKSA-N 0.000 description 2
- -1 enol esters Chemical class 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- 230000004992 fission Effects 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 1
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 1
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- ORNBQBCIOKFOEO-YQUGOWONSA-N Pregnenolone Natural products O=C(C)[C@@H]1[C@@]2(C)[C@H]([C@H]3[C@@H]([C@]4(C)C(=CC3)C[C@@H](O)CC4)CC2)CC1 ORNBQBCIOKFOEO-YQUGOWONSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- ADTNAQKEGWXKCL-UHFFFAOYSA-N acetohydrazide;pyridine Chemical compound CC(=O)NN.C1=CC=NC=C1 ADTNAQKEGWXKCL-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- AEMFNILZOJDQLW-QAGGRKNESA-N androst-4-ene-3,17-dione Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 AEMFNILZOJDQLW-QAGGRKNESA-N 0.000 description 1
- 229960005471 androstenedione Drugs 0.000 description 1
- AEMFNILZOJDQLW-UHFFFAOYSA-N androstenedione Natural products O=C1CCC2(C)C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 AEMFNILZOJDQLW-UHFFFAOYSA-N 0.000 description 1
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- GGCLNOIGPMGLDB-GYKMGIIDSA-N cholest-5-en-3-one Chemical compound C1C=C2CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 GGCLNOIGPMGLDB-GYKMGIIDSA-N 0.000 description 1
- NYOXRYYXRWJDKP-UHFFFAOYSA-N cholestenone Natural products C1CC2=CC(=O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 NYOXRYYXRWJDKP-UHFFFAOYSA-N 0.000 description 1
- KRVSOGSZCMJSLX-UHFFFAOYSA-L chromic acid Substances O[Cr](O)(=O)=O KRVSOGSZCMJSLX-UHFFFAOYSA-L 0.000 description 1
- IQFVPQOLBLOTPF-HKXUKFGYSA-L congo red Chemical compound [Na+].[Na+].C1=CC=CC2=C(N)C(/N=N/C3=CC=C(C=C3)C3=CC=C(C=C3)/N=N/C3=C(C4=CC=CC=C4C(=C3)S([O-])(=O)=O)N)=CC(S([O-])(=O)=O)=C21 IQFVPQOLBLOTPF-HKXUKFGYSA-L 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 150000002084 enol ethers Chemical class 0.000 description 1
- 150000002085 enols Chemical class 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 238000001640 fractional crystallisation Methods 0.000 description 1
- 238000010575 fractional recrystallization Methods 0.000 description 1
- AWJWCTOOIBYHON-UHFFFAOYSA-N furo[3,4-b]pyrazine-5,7-dione Chemical compound C1=CN=C2C(=O)OC(=O)C2=N1 AWJWCTOOIBYHON-UHFFFAOYSA-N 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 229960002847 prasterone Drugs 0.000 description 1
- ORNBQBCIOKFOEO-QGVNFLHTSA-N pregnenolone Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 ORNBQBCIOKFOEO-QGVNFLHTSA-N 0.000 description 1
- 229960000249 pregnenolone Drugs 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- 235000015500 sitosterol Nutrition 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 150000003460 sulfonic acids Chemical class 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 125000005208 trialkylammonium group Chemical group 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
Description
Verfahren zur Trennung der beim Seitenkettenabbau von Steroiden erhältlichen Carbonylverbindungen. Die Trennung der beim direkten oder stu fenweisen Seitenkettenabbau von Steroiden erhältlichen homologen Carbonylverbindun- gen und deren Derivate bietet, in bekannter weise, z. B. durch fraktionierte Kristalli sation ausgeführt, grosse Schwierigkeiten.
Auch mit den üblichen schwerlöslichen Car- bonylreagentien ist keine brauchbare Tren nung der Carbonylverbindungen unter sich zu erreichen und die ausgefällten Produkte enthalten immer eine gewisse Menge nicht- carbonylischer Anteile wie Ausgangsmateria lien und Oxydationszwischenprodukte. Da die als Hauptprodukt der Oxydation erhaltenen Ring-Carbonylverbindungen auf diese Weise nicht quantitativ isoliert werden können, wird die Gewinnung der Nebencarbonylver- bindungen erschwert.
Es wurde nun gefunden, dass eine Tren nung von beim Seitenkettenabbau von Steroi- den erhältlichen homologen gesättigten oder ungesättigten Carbonylverbindungen durch Umsetzung mit solchen Carbonylreagentien, die neben der zur Kondensation mit den Car- bonylgruppen befähigten Gruppen noch salzbildende Gruppen enthalten,
Abtrennung der Kondensationsprodukte und anschliessende Spaltung derselben gelingt, wenn man rohe oder vorgereinigte Gemische solcher homo loger Carbonylverbindungen mit den genann ten Carbonylreagentien umsetzt und das Ge misch der erhaltenen Kondensationsprodukte fraktionsweise zu den Carbonylverbindungen aufspaltet.
Gemische homologer gesättigter oder un gesättigter Carbonylverbindungen, welche dem vorliegenden Verfahren unterworfen werden können, sind zum Beispiel solche wie sie bei der Seitenkettenoxydation von bei spielsweise Cholestanolen, Cholesterin, Stigma sterin, Cinchol, Sitosterin, Ergosterin, Gallen säuren oder Stereoisomeren dieser Verbindun- gen, bezw. ihren Halogeniden oder Hydro- halogeniden, ihren Derivaten, wie Estern oder Xthern,
den entsprechenden Kern- carbonylverbindungen bezw. deren Enolderi- vaten. wie Enolestern oder Enoläthern ent stehen.
Geeignete Carbony lreagentien sind bei spielsweise: basische Hydrazide wie Trialkyl- ammonium- oder Pyridiniumfettsäurehydra- zide respektive ihre Salze, z. B. Trimethyl- ammoniumessigsäurehy drazid - Chlorid oder auch saure Hydrazide wie die Arylhydrazin- sulfonsäuren.
Das vorliegende Verfahren gestattet eitle Trennung von Carbonylverbindungen unter sich, da sich die Umsetzungsprodukte mit den angewandten Carbonylreagentien verschieden rasch spalten lassen. Das Verfahren gestal tet sich derart, dass man das neutrale Oxy dationsgemisch beispielsweise mit basischen Hydraziden bei erhöhter Temperatur voll ständig umsetzt und nach Entfernung nicht- earbonylischer Verbindungen, die bei ver schiedener Wasserstoffjonen - Konzentration jeweils freiwerdenden Ketone extrahiert.
Die Hydrazone der Methylketone zerfallen näm lich im allgemeinen schon in schwach saurer Lösung, während diejenigen der Ringketone in diesem Medium noch nicht gespalten sind. Die Trennung der Reaktionsprodukte gelingt zufolge der durch die An- oder Abwesenheit von salzbildenden Gruppen bedingten ver schiedenen Löslichkeit, z. B. in Lösungsmit teln, wie @Vasser. Glyzerinen, Glykolen einerseits und Äthern, Benzol und derglei chen anderseits. Das vorliegende Verfahren kann auch mit andern Reinigungs- bezw. Trennungsmethoden, -wie z. B.
Kristallisa tion, Überführung in Derivate, auswählende Adsorption und dergleichen kombiniert wer den.
Das neue Verfahren gestattet somit, die ausserordentlich wertvollen, durch unvoll ständigen Seitenkettenabbau entstehenden Carbonvlverbindungen auf einfache Weise zu isolieren und die Ausbeute an durch voll ständigen Seitenkettenabbau entstehenden Ringketonen zu vergrössern.
Beispiel <I>1:</I> Die bei der Oxydation von Cholesterin- dibromid-aeetat und nachfolgender Entbro- mierung erhaltenen neutralen Anteile wer den in methylalkoholischer Lösung, die 10 Eisessig enthält, mit dem Chlorid des Tri- methylammoniumessigsäurehydrazides durch halbstündiges Kochen umgesetzt. Die Lösung wird in soviel eishaltiges Wasser gegossen, dass die wässerige Lösun-- noch 10 bis 20 Alkohol enthält.
Hierauf neutralisiert man finit ? 11-Sodaliisung unter Kühlung /1o der Essigsäure und gewinnt die nichtketonischen Anteile durch erschöpfende Extraktion mit Äther.
Die wässerige Lösung wird nun mit n-Essigsiiure auf ein p1, das zwischen den Umsehlagspunkten voll Lackmusrot und Kon gorot liegt, gebracht. Bei. dieser Azidität wer den die Hydrazone der Methylketone, näm- lieh des .Pregneiioloiiacetats und Norchole- stenolonacet < i,ts, gespalten und letztere an schliessend durch Extraktion finit Äther iso liert.
Die Mutterlauge säuert nian mit Wein- @iurf,lü.sung an, bis sich Kongo grau färbt. Auch die neuen Spaltprodukte werden in Äther aufgenommen, die Ätherlösung mit Natriumbiearbonatlö suiig und Wasser ge waschen und über Natriumsulfat getrocknet.
Aus dem Riiekstand des Ätherauszuges wer den durell fraktionierte Umkristallisation aus 1Vlethatiol das bei 141. bis 1.42 schmelzende Noreliolestenolonaeetat und das Acetat des Pregnololis vom h'. 146 bis 147 rein er halten.
Nach Ansäuern der weinsauren Mut. terlauge finit starker Salzsäure -wird wie- derum mit Äther erschöpfend extrahiert und aus diesem Auszug das bei<B>170</B> bis<B>1</B> ( 2 schmelzende irans-Dehydroandrosteronacetat gewonnen.
Man kanil auch in wasserfreiem Medium arbeiten, derart, dass inan die methy lalko- lioliselie Reaktionslösung der basischen ffy- drazone mit hydroxylhaltigen Lösungsmit teln, wie Glykol. Glyzerin ete. versetzt. Die Hydrazone lösen sieh in letzteren und die nichtketonischen Anteile können mit nicht- hydroxylhaltigen 11itteln, z.
B. Äther, aus gezogen werden. Die fraktionierte Spaltung der gelösten geschieht dann in oben beschriebener Weise.
<I>Beispiel 2:</I> Eine methylalkoholische Lösung der bei der Oxydation von Cholestenon mit Chrom säure erhaltenen neutralen vom Ausgangs material befreiten Anteile werden mit 10% Eisessig und dem Chlorid des Trimethyl- ammoniumessigsäurehydrazides versetzt. Nach halbstündigem Sieden wird die Lösung in so viel Eiswasser gegossen, dass der Alkohol gehalt der wässerigen Lösung 20% nicht übersteigt. Ein Teil der Essigsäure wird nun neutralisiert und die schwach essigsaure Lösung nach Extraktion mit Äther mit so viel Weinsäurelösung versetzt, dass Kongo eben grau gefärbt wird.
Durch Ausziehen mit Äther und anschliessende Kristallisation aus verdünntem Alkohol gewinnt man Pregnendion vom F.<B>120'</B> und Norcholesten- dion, das bei<B>128'</B> schmilzt. Die weinsaure Mutterlauge wird sodann mit starker Salz säure angesäuert und wieder einer erschöp fenden Ätherextraktion unterworfen. Man wäscht die Ätherlösung mit Natriumbicar- bonatlösung und Wasser und trocknet über Natriumsulfat. Nach Verdampfen des Lö sungsmittels erhält man durch Umkristalli sation aus Hexan oder wässerigem Alkohol reines Androstendion vom F. 173 bis 174'.
<I>Beispiel 3:</I> Das bei der Oxydation von Cholesterin dibromid-acetat, nachfolgender Entbromie- rung und Verseifung erhaltene Oxyketon- gemisch wird in alkoholischer Lösung, die 10% Eisessig enthält, mit dem Chlorid des Pyridiniumessigsäurehydrazides durch ein- stündiges Kochen umgesetzt. Die Lösung wird in soviel eishaltiges Wasser gegossen, dass die wässerige Lösung noch 10 bis 20 Alkohol enthält.
Hierauf neutralisiert man mit 2n-Natronlauge '/"o der Essigsäure unter Kühlung und gewinnt die nichtketonischen Anteile durch erschöpfende Extraktion mit Äther. Man versetzt hierauf die Mutterlauge mit soviel Essigsäure, dass sich Kongo grau färbt. Die im Äther aufgenommenen Spalt produkte werden neutral gewaschen und ge trocknet. Aus dem Rückstand des Äther auszuges wird nach Umkristallisation aus Al kohol vorwiegend Norcholestenon vom F. 127 bis 128 erhalten.
Die wässerige Mutter- lauge wird nun mit 2n-Salzsäure gerade kongosauer gestellt. Aus den bei dieser Azi- dität entstehenden Spaltprodukten isoliert man nach Aufarbeitung Pregnenolonfrak- tionen mit F. 188 bis 193 .
Man lässt die mit konzentrierter Salzsäure versetzte Mutterlauge einige Zeit stehen und unterwirft sie hierauf einer erschöpfenden Extraktion mit Äther. Aus diesem Äther auszug gewinnt man das bei 142 und 148 schmelzende trans-Dehydroandrosteron.
Die Einstellung der Wasserstoffionen konzentration kann selbstverständlich auch mit andern hierzu gebräuchlichen Mitteln er reicht werden.
Process for separating the carbonyl compounds obtainable in the side chain degradation of steroids. The separation of the homologous carbonyl compounds and their derivatives obtainable in the direct or stepwise degradation of the side chains of steroids offers, in a known manner, e.g. B. carried out by fractional crystallization, great difficulties.
Even with the usual sparingly soluble carbonyl reagents, no useful separation of the carbonyl compounds among themselves can be achieved and the precipitated products always contain a certain amount of non-carbonylic components such as starting materials and oxidation intermediates. Since the ring carbonyl compounds obtained as the main product of the oxidation cannot be isolated quantitatively in this way, the recovery of the secondary carbonyl compounds is made more difficult.
It has now been found that a separation of homologous saturated or unsaturated carbonyl compounds obtainable in the side chain degradation of steroids by reaction with such carbonyl reagents which, in addition to the groups capable of condensation with the carbonyl groups, also contain salt-forming groups,
Separation of the condensation products and subsequent cleavage of the same are possible if crude or prepurified mixtures of such homologous carbonyl compounds are reacted with the carbonyl reagents mentioned and the mixture of the condensation products obtained is split up fractionally to give the carbonyl compounds.
Mixtures of homologous saturated or unsaturated carbonyl compounds which can be subjected to the present process are, for example, those as they are used in the side chain oxidation of, for example, cholestanols, cholesterol, stigma sterol, cinchol, sitosterol, ergosterol, bile acids or stereoisomers of these compounds, respectively their halides or hydrohalides, their derivatives, such as esters or ethers,
the corresponding core carbonyl compounds respectively. their enol derivatives. how enol esters or enol ethers arise.
Suitable carbonyl reagents are, for example: basic hydrazides such as trialkylammonium or pyridinium fatty acid hydrazides or their salts, eg. B. Trimethylammoniumessigsäurehy drazid - chloride or acid hydrazides such as the arylhydrazine sulfonic acids.
The present process permits vain separation of carbonyl compounds from one another, since the reaction products can be cleaved at different speeds with the carbonyl reagents used. The process is such that the neutral oxidation mixture is fully reacted, for example, with basic hydrazides at elevated temperature and, after removal of non-carbonylic compounds, the ketones released at different hydrogen ion concentrations are extracted.
The hydrazones of the methyl ketones generally disintegrate even in weakly acidic solution, whereas those of the ring ketones are not yet split in this medium. The separation of the reaction products succeeds according to the different solubility caused by the presence or absence of salt-forming groups, eg. B. in solvents like @Vasser. Glycerines, glycols on the one hand and ethers, benzene and the like on the other hand. The present process can also be used with other cleaning or cleaning. Separation methods, such as B.
Crystallization, conversion into derivatives, selective adsorption and the like combined who.
The new process thus makes it possible to isolate, in a simple manner, the extraordinarily valuable carbon film compounds formed by incomplete side chain degradation and to increase the yield of ring ketones formed by complete side chain degradation.
Example <I> 1: </I> The neutral components obtained in the oxidation of cholesterol dibromide acetate and subsequent debromination are reacted in a methyl alcoholic solution containing glacial acetic acid with the chloride of trimethylammonium acetic acid hydrazide by boiling for half an hour . The solution is poured into enough ice-containing water that the aqueous solution still contains 10 to 20 alcohol.
Is this a finite neutralization? 11-sodalization with cooling / 1o of the acetic acid and the non-ketonic components are obtained by exhaustive extraction with ether.
The aqueous solution is then brought with n-acetic acid to a p1, which lies between the turnover points full litmus red and congo red. At. With this acidity, the hydrazones of the methyl ketones, namely of the Pregneiioloiacetate and Norcholestenolone Acetate, are cleaved and the latter is then isolated by extraction in finite ether.
The mother liquor is acidified with Wein- @ iurf, solution until the Congo turns gray. The new fission products are also taken up in ether, the ether solution is washed with sodium carbonate solution and water and dried over sodium sulphate.
From the back of the ether extract, the durell fractional recrystallization from 1Vlethatiol, the noreliolestenolonaeetat, which melts at 141st to 1.42nd, and the acetate of the Pregnololis from h '. 146 to 147 kept pure.
After acidifying the tartaric courage. Lye finitely strong hydrochloric acid is again extracted exhaustively with ether and from this extract the irans dehydroandrosterone acetate which melts at <B> 170 </B> to <B> 1 </B> (2) is obtained.
It is also possible to work in an anhydrous medium, in such a way that the methylalkolioliselie reaction solution of the basic fluoride zone with hydroxyl-containing solvents such as glycol. Glycerin ete. offset. The hydrazones dissolve in the latter and the non-ketonic components can be mixed with non-hydroxyl-containing agents, e.g.
B. ether, to be drawn from. The fractional cleavage of the dissolved then takes place in the manner described above.
<I> Example 2: </I> A methyl alcoholic solution of the neutral fractions freed from the starting material obtained in the oxidation of cholestenone with chromic acid are mixed with 10% glacial acetic acid and the chloride of trimethylammonium acetic acid hydrazide. After boiling for half an hour, the solution is poured into so much ice water that the alcohol content of the aqueous solution does not exceed 20%. Part of the acetic acid is now neutralized and, after extraction with ether, the weakly acetic acid solution is mixed with enough tartaric acid solution that Congo is colored gray.
Pregnendione from F. <B> 120 '</B> and norcholestedione, which melts at <B> 128' </B>, is obtained by extraction with ether and subsequent crystallization from dilute alcohol. The tartaric mother liquor is then acidified with strong hydrochloric acid and again subjected to an exhaustive ether extraction. The ether solution is washed with sodium bicarbonate solution and water and dried over sodium sulfate. After evaporation of the solvent, pure androstenedione with a melting point of 173 to 174 'is obtained by recrystallization from hexane or aqueous alcohol.
<I> Example 3: </I> The oxyketone mixture obtained in the oxidation of cholesterol dibromide acetate, subsequent debromination and saponification is in an alcoholic solution containing 10% glacial acetic acid with the chloride of pyridinium acetic acid hydrazide for one hour Cooking implemented. The solution is poured into enough ice-containing water that the aqueous solution still contains 10 to 20 alcohol.
The acetic acid is then neutralized with 2N sodium hydroxide solution, while cooling, and the non-ketonic components are recovered by exhaustive extraction with ether. Acetic acid is then added to the mother liquor to make the Congo gray. The fission products absorbed in the ether are washed neutral and dried. From the residue of the ether extract, after recrystallization from alcohol, mainly norcholestenone with a melting point of 127 to 128 is obtained.
The aqueous mother liquor is now acidified to the Congo with 2N hydrochloric acid. After work-up, pregnenolone fractions with F. 188 to 193 are isolated from the cleavage products formed at this acidity.
The mother liquor mixed with concentrated hydrochloric acid is left to stand for some time and then subjected to an exhaustive extraction with ether. The trans-dehydroandrosterone which melts at 142 and 148 is obtained from this ether extract.
The adjustment of the hydrogen ion concentration can of course also be achieved with other means commonly used for this purpose.
Claims (1)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH207499T | 1937-08-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH207499A true CH207499A (en) | 1939-11-15 |
Family
ID=4445571
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH207499D CH207499A (en) | 1937-08-04 | 1937-08-04 | Process for separating the carbonyl compounds obtainable in the side chain degradation of steroids. |
Country Status (1)
| Country | Link |
|---|---|
| CH (1) | CH207499A (en) |
-
1937
- 1937-08-04 CH CH207499D patent/CH207499A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH207499A (en) | Process for separating the carbonyl compounds obtainable in the side chain degradation of steroids. | |
| DE681868C (en) | Process for the preparation of pregnanolone and allopregnanolone or their derivatives | |
| DE767726C (en) | Process of oxidative degradation of the side chain of sterol compounds | |
| DE873699C (en) | Process for the preparation of oxygen-rich derivatives of unsaturated compounds of the androstane and pregnane series | |
| DE676115C (en) | Process for the direct production of OEstradiol from hormone mixtures containing, in addition to equilenin and equilin, also OEstron | |
| AT160572B (en) | Process for the preparation of unsaturated oxyketones of the cyclopentanopolydrophenanthrene series or their derivatives. | |
| DE937349C (en) | Process for the separation and purification of ketosteroids | |
| DE686759C (en) | andions | |
| AT160800B (en) | Process for the separation of unsaturated diketones of the cyclopentanopolyhydrophenanthrene series from sterol-oxidation mixtures. | |
| AT160395B (en) | Process for the preparation of monohalogen compounds of saturated ketones or of unsaturated ketones of the pregnane series. | |
| AT164549B (en) | Process for the production of sterol degradation products | |
| AT158152B (en) | Process for the separation of mixtures of stereoisomeric alcohols of the androstane series. | |
| DE889442C (en) | Process for the preparation of 17-oxo and 17-oxy compounds of the oestran series | |
| DE875352C (en) | Process for the production of androstandionen-3, 17 halogenated in ring A | |
| AT218182B (en) | Process for the preparation of an acyloxy derivative of Δ 5, 16-Pregnadien-3 β-o1-20-one | |
| DE748538C (en) | Process for the preparation of polynuclear substituted unsaturated ring ketones | |
| CH204519A (en) | Process for the oxidative degradation of the side chain of sterol compounds. | |
| DE698910C (en) | gmasterin | |
| DE699308C (en) | Process for the production of polynuclear substituted ring ketones from sterols and bile acids | |
| AT164550B (en) | Process for the production of new derivatives of steroid alcohols | |
| AT146825B (en) | Process for the preparation of polynuclear substituted ring ketones. | |
| DE752752C (en) | Process for the preparation of steroid compounds aromatized in ring A. | |
| DE758807C (en) | Process for the preparation of new oxyketones or their esters | |
| CH193220A (en) | Process for the production of a polynuclear unsaturated ring ketone. | |
| DE823883C (en) | Process for the production of hormones of the adrenal cortex |